Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Anemia 4 Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Hematologic Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Transfusion Reaction 1 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Participation 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Hemorrhage 1 Carcinoma, Non-Small-Cell Lung 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Failure Disorders 1 Anemia, Sickle Cell 1 Anemia, Aplastic 1

Interventions

Gemcitabine 157 Cisplatin 117 pembrolizumab 81 Cystectomy 46 Nivolumab 42 Carboplatin 42 Paclitaxel 41 Mitomycin 41 Docetaxel 39 atezolizumab 33 Magnetic Resonance Spectroscopy 33 Radiotherapy 31 durvalumab 30 avelumab 26 BCG Vaccine 26 Specimen Handling 25 Cystoscopy 24 enfortumab vedotin 23 Doxorubicin 23 Fluorouracil 20 Methotrexate 17 Vinblastine 16 Standard of Care 15 Ipilimumab 14 Filgrastim 14 5-aminolevulinic acid hexyl ester 14 Transurethral Resection of Bladder 13 Surgical Procedures, Operative 13 Sunitinib 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Blood Transfusion × Clear all

NCT04537221 2020-11-25

NorCys-Transf

Turku University Hospital

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡